Elanco Animal Health Incorporated
ELAN
$17.80
-$0.165-0.92%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.81% | -1.00% | -1.45% | -3.56% | 12.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.81% | -1.00% | -1.45% | -3.56% | 12.02% |
| Cost of Revenue | 6.67% | -1.17% | -2.91% | 1.03% | 14.06% |
| Gross Profit | 3.48% | -0.87% | 0.00% | -7.40% | 10.59% |
| SG&A Expenses | 12.99% | 1.19% | 2.44% | 3.19% | 0.28% |
| Depreciation & Amortization | 3.82% | -3.76% | -5.80% | -5.00% | -3.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.14% | 0.00% | -1.37% | 0.88% | 6.47% |
| Operating Income | -26.09% | -9.02% | -6.67% | -111.90% | 116.98% |
| Income Before Tax | 178.13% | 400.00% | 59.84% | 150.96% | 59.49% |
| Income Tax Expenses | -22.22% | 65.00% | -407.14% | 19,600.00% | 0.00% |
| Earnings from Continuing Operations | 122.00% | 109.38% | 94.33% | 133.21% | 48.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 122.00% | 109.38% | 94.33% | 133.21% | 48.45% |
| EBIT | -26.09% | -9.02% | -6.67% | -111.90% | 116.98% |
| EBITDA | -7.87% | -5.54% | 4.55% | -23.26% | 16.09% |
| EPS Basic | 121.94% | 108.47% | 94.34% | 133.10% | 48.60% |
| Normalized Basic EPS | -46.13% | 18.50% | 44.18% | -63.43% | 264.95% |
| EPS Diluted | 119.76% | 116.67% | 93.26% | 132.82% | 49.40% |
| Normalized Diluted EPS | -46.46% | 18.19% | 44.18% | -62.42% | 264.95% |
| Average Basic Shares Outstanding | 0.49% | 0.39% | 0.32% | 0.32% | 0.32% |
| Average Diluted Shares Outstanding | 1.19% | 0.63% | 0.32% | 1.01% | 0.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |